162 related articles for article (PubMed ID: 22698405)
1. A TARBP2-dependent miRNA expression profile underlies cancer stem cell properties and provides candidate therapeutic reagents in Ewing sarcoma.
De Vito C; Riggi N; Cornaz S; Suvà ML; Baumer K; Provero P; Stamenkovic I
Cancer Cell; 2012 Jun; 21(6):807-21. PubMed ID: 22698405
[TBL] [Abstract][Full Text] [Related]
2. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.
Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L
In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355
[TBL] [Abstract][Full Text] [Related]
3. Targeting cancer stem-like cells as an approach to defeating cellular heterogeneity in Ewing sarcoma.
Cornaz-Buros S; Riggi N; DeVito C; Sarre A; Letovanec I; Provero P; Stamenkovic I
Cancer Res; 2014 Nov; 74(22):6610-22. PubMed ID: 25261238
[TBL] [Abstract][Full Text] [Related]
4. Multipotent adult germline stem cells and embryonic stem cells have similar microRNA profiles.
Zovoilis A; Nolte J; Drusenheimer N; Zechner U; Hada H; Guan K; Hasenfuss G; Nayernia K; Engel W
Mol Hum Reprod; 2008 Sep; 14(9):521-9. PubMed ID: 18697907
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
Xia H; Hui KM
Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA expression profile of colon cancer stem-like cells in HT29 adenocarcinoma cell line.
Zhang H; Li W; Nan F; Ren F; Wang H; Xu Y; Zhang F
Biochem Biophys Res Commun; 2011 Jan; 404(1):273-8. PubMed ID: 21130073
[TBL] [Abstract][Full Text] [Related]
7. EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells.
Riggi N; Suvà ML; De Vito C; Provero P; Stehle JC; Baumer K; Cironi L; Janiszewska M; Petricevic T; Suvà D; Tercier S; Joseph JM; Guillou L; Stamenkovic I
Genes Dev; 2010 May; 24(9):916-32. PubMed ID: 20382729
[TBL] [Abstract][Full Text] [Related]
8. Differentially expressed microRNAs in pancreatic cancer stem cells.
Jung DE; Wen J; Oh T; Song SY
Pancreas; 2011 Nov; 40(8):1180-7. PubMed ID: 21785383
[TBL] [Abstract][Full Text] [Related]
9. Inability of human induced pluripotent stem cell-hematopoietic derivatives to downregulate microRNAs in vivo reveals a block in xenograft hematopoietic regeneration.
Risueño RM; Sachlos E; Lee JH; Lee JB; Hong SH; Szabo E; Bhatia M
Stem Cells; 2012 Feb; 30(2):131-9. PubMed ID: 22131151
[TBL] [Abstract][Full Text] [Related]
10. The role of TARBP2 in the development and progression of cancers.
Yu X; Li Z
Tumour Biol; 2016 Jan; 37(1):57-60. PubMed ID: 26486325
[TBL] [Abstract][Full Text] [Related]
11. Genomic analysis of prostate cancer stem cells isolated from a highly metastatic cell line.
Rowehl RA; Crawford H; Dufour A; Ju J; Botchkina GI
Cancer Genomics Proteomics; 2008; 5(6):301-10. PubMed ID: 19287071
[TBL] [Abstract][Full Text] [Related]
12. Cloning of the nucleostemin gene and its function in transforming human embryonic bone marrow mesenchymal stem cells into F6 tumor cells.
Han C; Zhang X; Xu W; Wang W; Qian H; Chen Y
Int J Mol Med; 2005 Aug; 16(2):205-13. PubMed ID: 16012751
[TBL] [Abstract][Full Text] [Related]
13. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme.
Broadley KW; Hunn MK; Farrand KJ; Price KM; Grasso C; Miller RJ; Hermans IF; McConnell MJ
Stem Cells; 2011 Mar; 29(3):452-61. PubMed ID: 21425408
[TBL] [Abstract][Full Text] [Related]
14. miRNAs expressed differently in cancer stem cells and cancer cells of human gastric cancer cell line MKN-45.
Golestaneh AF; Atashi A; Langroudi L; Shafiee A; Ghaemi N; Soleimani M
Cell Biochem Funct; 2012 Jul; 30(5):411-8. PubMed ID: 22374783
[TBL] [Abstract][Full Text] [Related]
15. Ewing's sarcoma cancer stem cell targeted therapy.
Todorova R
Curr Stem Cell Res Ther; 2014 Jan; 9(1):46-62. PubMed ID: 24294922
[TBL] [Abstract][Full Text] [Related]
16. Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer.
Musumeci M; Coppola V; Addario A; Patrizii M; Maugeri-Saccà M; Memeo L; Colarossi C; Francescangeli F; Biffoni M; Collura D; Giacobbe A; D'Urso L; Falchi M; Venneri MA; Muto G; De Maria R; Bonci D
Oncogene; 2011 Oct; 30(41):4231-42. PubMed ID: 21532615
[TBL] [Abstract][Full Text] [Related]
17. Anchorage-independent growth of Ewing sarcoma cells under serum-free conditions is not associated with stem-cell like phenotype and function.
Leuchte K; Altvater B; Hoffschlag S; Potratz J; Meltzer J; Clemens D; Luecke A; Hardes J; Dirksen U; Juergens H; Kailayangiri S; Rossig C
Oncol Rep; 2014 Aug; 32(2):845-52. PubMed ID: 24927333
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA expression profile of gastric cancer stem cells in the MKN-45 cancer cell line.
Liu J; Ma L; Wang Z; Wang L; Liu C; Chen R; Zhang J
Acta Biochim Biophys Sin (Shanghai); 2014 Feb; 46(2):92-9. PubMed ID: 24384510
[TBL] [Abstract][Full Text] [Related]
19. Modulation of microRNAs for potential cancer therapeutics.
Wu W
Methods Mol Biol; 2011; 676():59-70. PubMed ID: 20931390
[TBL] [Abstract][Full Text] [Related]
20. Long-term culture following ES-like gene-induced reprogramming elicits an aggressive phenotype in mutated cholangiocellular carcinoma cells.
Nagai K; Ishii H; Miyoshi N; Hoshino H; Saito T; Sato T; Tomimaru Y; Kobayashi S; Nagano H; Sekimoto M; Doki Y; Mori M
Biochem Biophys Res Commun; 2010 Apr; 395(2):258-63. PubMed ID: 20381452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]